Santosh Kesari
Affiliations: | Neurosciences | University of California, San Diego, La Jolla, CA |
Google:
"Santosh Kesari"Mean distance: 106866
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Goldman S, Margol A, Hwang EI, et al. (2022) Safety of Tumor Treating Fields (TTFields) therapy in pediatric patients with malignant brain tumors: Post-marketing surveillance data. Frontiers in Oncology. 12: 958637 |
| Park JH, de Lomana ALG, Marzese DM, et al. (2021) A Systems Approach to Brain Tumor Treatment. Cancers. 13 |
| Rodvold JJ, Xian S, Nussbacher J, et al. (2020) IRE1α and IGF signaling predict resistance to an endoplasmic reticulum stress-inducing drug in glioblastoma cells. Scientific Reports. 10: 8348 |
| Kim MM, Parmar HA, Schipper M, et al. (2020) BRAINSTORM: A Multi-Institutional Phase I/II Study of RRx-001 in Combination with Whole Brain Radiation Therapy for Patients with Brain Metastases. International Journal of Radiation Oncology, Biology, Physics |
| Kumthekar P, Tang SC, Brenner AJ, et al. (2020) ANG1005, a brain penetrating peptide-drug conjugate, shows activity in patients with breast cancer with leptomeningeal carcinomatosis and recurrent brain metastases. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research |
| Singh VM, Fisher DM, Berz D, et al. (2020) The next generation of cerebrospinal fluid (CSF)-based molecular diagnostics: Improving sensitivity and actionability in breast and lung cancer patients with CNS involvement. Journal of Clinical Oncology. 38: e14502-e14502 |
| Sampson JH, Achrol A, Aghi MK, et al. (2020) MDNA55 survival in recurrent glioblastoma (rGBM) patients expressing the interleukin-4 receptor (IL4R) as compared to a matched synthetic control. Journal of Clinical Oncology. 38: 2513-2513 |
| Bota DA, Duma CM, Kesari S, et al. (2020) Abstract CT182: Adjunctive treatment of primary glioblastoma with patient-specific dendritic cell vaccines pulsed with antigens from self-renewing autologous tumor cells: A phase II trial Cancer Research. 80 |
| Loya J, Zhang C, Cox E, et al. (2019) Biological intratumoral therapy for the high-grade glioma part I: intratumoral delivery and immunotoxins. Cns Oncology. 8: CNS38 |
| Loya J, Zhang C, Cox E, et al. (2019) Biological intratumoral therapy for the high-grade glioma part II: vector- and cell-based therapies and radioimmunotherapy. Cns Oncology. 8: CNS40 |